NIH-funded research Fellowship grant

Understanding how genetic differences in antibodies affect responses to HIV

Official title: The Role of Immunoglobulin Genetic Diversity in the Development of Neutralizing Antibodies Against HIV Env Protein

Funded at Emory University · NIH-11054547 · Data updated 2026-11-12

This study is looking at how differences in our genes affect how well our bodies can make antibodies to fight HIV, which could help improve vaccines and treatments for people living with the virus.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startMarch 1, 2024
Project endFebruary 28, 2027
Funding year2025
Award (this year)$48,974
NIH project number5F31AI179463-02
Project IDNIH-11054547 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals living with HIV who have varying responses to treatment or vaccination.

Less likely to help

Patients who are not infected with HIV or those who do not have a history of vaccination against HIV may not benefit from this research.

What this research studies

This research investigates the role of genetic diversity in immunoglobulin antibodies and how it influences the body's ability to produce neutralizing antibodies against the HIV virus. By examining variations in the immunoglobulin heavy chain gene, the study aims to uncover why some individuals develop strong antibody responses to HIV while others do not. The research will utilize both human samples and animal models to explore these genetic factors and their impact on immune responses. Patients may benefit from insights that could lead to improved vaccine strategies and treatments for HIV.

Why it matters

Potential benefit: If successful, this research could enhance the development of more effective vaccines and therapies for HIV, potentially improving outcomes for patients living with the virus.

How similar studies have gone: Previous research has shown that understanding genetic diversity in immune responses can lead to significant advancements in vaccine development, indicating a promising avenue for this study.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Edwards, Christopher — Emory University
  • Study coordinator: Edwards, Christopher

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.